Cultured human monocytes secrete fibronectin in response to activation by proinflammatory cytokines

Clinical and Experimental Immunology

Volumn 120, Issue 1, 2000, Pages 66-70

  Kitamura, N ^a,b   Nishinarita, S ^a   Takizawa, T ^a   Tomita, Y ^a   Horie, T ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Cytokine; Fibronectin; Monocyte

Indexed keywords

CYTOKINE; FIBRONECTIN;

ARTICLE; CELL CULTURE; CELL STIMULATION; CYTOKINE RELEASE; DRUG EFFECT; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MONOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; T LYMPHOCYTE ACTIVATION; WOUND HEALING;

EID: 0034028654     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01162.x     Document Type: Article

References (28)

1. Hayashi M, Yamada KM. Domain structure of the carboxyl half of human plasma fibronectin. J Biol Chem 1983; 258:3332-40.
2. Rennard SI, Chen YF, Robbins RA, Gadek JE, Crystal GG. Fibronectin mediates cell attachment to Clq: a mechanism for the localization of fibrosis in inflammatory disease. Clin Exp Immunol 1983; 54:239-47.
3. Tada K, Tuan T-L, Brown PJ, Brown PJ, Grinnell F. Fibronectin receptors of human keratinocytes and their expression during cell culture. J Cell Biol 1987; 105:3097-104.
4. Albelda SM, Buck CA. Integrin and other cell adhesion molecules. FASEB J 1990; 4:2868-79.
5. Shimizu Y, Seventer GAV, Horgan KJ, Horgan KJ, Shaw S. Costimulation of proliferative responses of resting CD4 + T cell by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J Immunol 1990; 145:59-67.
6. Nojima Y, Humphries MJ, Mould AP, Komoriya A, Yamada KM. VLA-4 mediates CD3-dependent CD4 + T cell activation via the CS1 alternatively spliced domain of fibronectin. J Exp Med 1990; 172:1185-92.
7. Davis LS, Oppenheimer-Marks N, Bednarczyk JL, Mcintyre BW, Lipsky PE. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules. J Immunol 1990; 145:785-93.
8. Yamada A, Nikaido T, Nojima Y, Schlossman SF, Morimoto C. Activation of human CD4 + T lymphocyte. Interaction of fibronectin with VLA-5 receptor on CD4 cells induces the AP-1 transcription factor. J Immunol 1991; 146:53-56.
9. Nishinarita S, Yamamoto T, Takizawa T, Hayakawa J, Karasaki M, Sawada S. Increased plasma fibronectin in patients with systemic lupus erythematosus. Clin Rheumatol 1990; 9:214-9.
10. Takizawa T, Nishinarita S, Kitamamura N et al. Interaction of the cell-binding domain of fibronectin with VLA-5 integrin induces monokine production in cultured human monocytes. Clin Exp Immunol 1995; 101:376-82.
11. Boyum A. Isolation of lymphocytes, granulocytes macrophages. Scand J Immunol 1976; 5 (Suppl.):9-15.
12. Riet VI, Greef DC, Favero DH, Demanet C, Camp BV. Production of fibronectin and adherence to fibronectin by human melanoma cell line. Br J Haematol 1994; 87:258-65.
13. De Waal Malefyt R, Fidgor CG, Huijbens R et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993; 151:6370-81.
14. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clones: definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-57.
15. Mosmann TR, Coffmann RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 1989; 7:145-73.
16. Abbas KA, Williams ME, Burstein HJ, Chang TL, Lichtman AH. Activation and functions of CD4 + T-cell subsets. Immunol Rev 1991; 123:5-22.
17. Mosmann TR, Schumacher JH, Street NF et al. Diversity of cytokine synthesis and function of mouse CD4 + T cells. Immunol Rev 1991; 123:209-29.
18. Owen MR, Cimino CD. Synthesis of fibronectin by the isolated perfused rat liver. Blood 1980; 59:1305-9.
19. Schmidt ME, Dougias SD. Disappearance and recovery of human monocyte IgG receptor activity after phagocytosis. J Immunol 1972; 109:914-7.
20. Haakenstad AO, Mannik M. Saturation of the reticuloendothelial system with soluble immune complexes. J Immumol 1974; 112:1939-48.
21. Alitalo K, Hovi T, Vaheri A. Fibronectin is produced by human macrophages. J Exp Med 1980; 151:602-13.
22. Carsons S, Parenti D, Lavietes BB, Diamond HS, Singer A, Boxer M. Plasma fibronectin in systemic lupus erythematosus relationship to clinical activity, DNA binding and acute phase proteins. J Rheumatol 1985; 12:1088-92.
23. Scott DL, Wainwright AC, Walton KW, Williamson N. Significance of fibronectin in rheumatoid arthritis and osteoarthritis. Ann Rheum 1981; 40:142-53.
24. Scott DL, Walton KW. The significance of fibronectin in rheumatoid arthritis. Semin Arthritis Rheum 1984; 13:244-54.
25. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin Exp Immunol 1995; 99:331-9.
26. Yano S, Sone S, Nishioka Y, Mukaida N, Matsushima K, Ogura T. Differential effects of anti-inflammatory cytokines (IL-4, IL-10 and IL-13) on tumoricidal and chemotactic properties of human monocytes induced by monocyte chemotactic and activating factor. J Leuk Biol 1995; 57:303-9.
27. Kucharzik T, Lgering N, Adolf M, Domschke W, Stoll R. Synergistic effect of immunoregulatory cytokine on peripheral blood monocytes from patients with inflammatory bowel disease. Dig Dis Sci 1997; 42:805-12.
28. Hart PH, Ahern MJ, Jones CA, Jones KL, Jones KL, Smith MD, Finlay-Jones JJ. Synovial fluid macrophages and blood monocytes differ in their responses to IL-4. J Immunol 1993; 151:3370-80.